Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69M Sell
1,855
-31
-2% -$49.3K 0.01% 210
2026
Q1
$2.49M Sell
1,886
-795
-30% -$1.09M 0.01% 217
2025
Q4
$2.87M Sell
2,681
-238
-8% -$248K 0.01% 221
2025
Q3
$2.83M Sell
2,919
-35
-1% -$27.5K 0.01% 213
2025
Q2
$2.37M Sell
2,954
-104
-3% -$74.6K 0.01% 223
2025
Q1
$2.03M Sell
3,058
-346
-10% -$252K 0.01% 224
2024
Q4
$2.36M Buy
3,404
+428
+14% +$307K 0.01% 215
2024
Q3
$2.48M Buy
2,976
+12
+0.4% +$10.7K 0.01% 219
2024
Q2
$3.03M Sell
2,964
-215
-7% -$207K 0.01% 213
2024
Q1
$3.09M Sell
3,179
-17
-0.5% -$15.1K 0.01% 214
2023
Q4
$2.42M Sell
3,196
-75
-2% -$49.5K 0.01% 219
2023
Q3
$1.93M Buy
+3,271
New +$2.17M 0.01% 227

Other funds holding ASML

EARNEST Partners's ASML Position: Q2 2026 in Review

EARNEST Partners reduced its ASML (ASML) stake by 1.6% in Q2 2026, selling an estimated $49.3K and leaving 1,855 shares worth $3.69M. The position accounts for 0.01% of the portfolio, ranked #210.

EARNEST Partners first reported a position in ASML in Q3 2023 and has held it in 12 quarters since. 2,498 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • EARNEST Partners held 1,855 shares of ASML worth $3.69M as of Q2 2026.
  • EARNEST Partners sold 31 ASML shares in Q2 2026, an estimated $49.3K.
  • ASML made up 0.01% of EARNEST Partners's portfolio in Q2 2026, its #210 holding.
  • EARNEST Partners first reported a position in ASML in Q3 2023 and has held it in 12 quarters since.
  • 2,498 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on EARNEST Partners's 13F filing for Q2 2026, filed 13 Aug 2026.